AAAAAA
Results: 1-25/37
Authors:
Van Mieghem, A
Fonck, C
Coosemans, W
Vandeleene, B
Vanrenterghem, Y
Squifflet, JP
Pirson, Y
Citation: A. Van Mieghem et al., Outcome of cadaver kidney transplantation in 23 patients with type 2 diabetes mellitus, NEPH DIAL T, 16(8), 2001, pp. 1686-1691
Authors:
De Smet, A
Kuypers, D
Evenepoel, P
Maes, B
Messiaen, T
Van Damme, B
Vanrenterghem, Y
Citation: A. De Smet et al., 'Full house' positive immunohistochemical membranoproliferative glomerulonephritis in a patient with portosystemic shunt, NEPH DIAL T, 16(11), 2001, pp. 2258-2262
Authors:
Hendrickx, L
Kuypers, D
Evenepoel, P
Maes, B
Messiaen, T
Vanrenterghem, Y
Citation: L. Hendrickx et al., A comparative prospective study on the use of low concentrate citrate lockversus heparin lock in permanent dialysis catheters, INT J ARTIF, 24(4), 2001, pp. 208-211
Authors:
Geerinck, K
Lukito, G
Snoeck, R
De Vos, R
De Clercq, E
Vanrenterghem, Y
Degreef, H
Maes, B
Citation: K. Geerinck et al., A case of human orf in an immunocompromised patient treated successfully with cidofovir cream, J MED VIROL, 64(4), 2001, pp. 543-549
Authors:
Coosemans, W
Baert, L
Kuypers, D
Maes, B
Messiaen, T
Vanrenterghem, Y
Pirenne, J
Citation: W. Coosemans et al., Renal transplantation onto abnormal urinary tract: Ileal conduit urinary diversion, TRANSPLAN P, 33(4), 2001, pp. 2493-2494
Authors:
Vanrenterghem, Y
Citation: Y. Vanrenterghem, The art of immunosuppression: Tailoring therapy for the future, TRANSPLAN P, 33(3A), 2001, pp. 1S-1S
Authors:
Vanrenterghem, Y
Citation: Y. Vanrenterghem, Posttransplant cardiovascular risk: Impact on long-term patient survival -Proceedings of a CME-accredited Meeting Held in Chicago, Illinois, USA March 13, 2000 - Introduction, TRANSPLANT, 72(6), 2001, pp. S4-S4
Authors:
Squifflet, JP
Backman, L
Claesson, K
Dietl, KH
Ekberg, H
Forsythe, JLR
Kunzendorf, U
Heemann, U
Land, W
Morales, JM
Muhlbacher, F
Talbot, D
Taube, D
Tyden, G
van Hooff, J
Schleibner, S
Vanrenterghem, Y
Citation: Jp. Squifflet et al., Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients, TRANSPLANT, 72(1), 2001, pp. 63-69
Authors:
Schepens, D
Verswijvel, G
Kuypers, D
Vanrenterghem, Y
Citation: D. Schepens et al., Renal cortical nephrocalcinosis, NEPH DIAL T, 15(7), 2000, pp. 1080-1082
Authors:
Meeus, G
Messiaen, T
Verhoef, G
Vanrenterghem, Y
Citation: G. Meeus et al., Nem-onset anaemia following kidney transplantation, NEPH DIAL T, 15(12), 2000, pp. 2059-2061
Authors:
Cohen, B
Persijn, GG
Vanrenterghem, Y
Citation: B. Cohen et al., Commerce in transplantation: how does it affect European legislation?, CLIN TRANSP, 14(1), 2000, pp. 28-31
Authors:
Messiaen, T
Van Damme, B
Kuypers, D
Maes, B
Vanrenterghem, Y
Citation: T. Messiaen et al., Crescentic glomerulonephritis complicating the course of a hypocomplementemic urticarial vasculitis, CLIN NEPHR, 54(5), 2000, pp. 409-412
Authors:
Maes, B
Van Mieghem, A
Messiaen, T
Kuypers, D
Van Damme, B
Vanrenterghem, Y
Citation: B. Maes et al., Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type, AM J KIDNEY, 36(3), 2000, pp. NIL_49-NIL_53
Authors:
Vanrenterghem, Y
Citation: Y. Vanrenterghem, Non-heart-beating donors for renal transplantation - Reply, LANCET, 356(9244), 2000, pp. 1854-1854
Authors:
Vanrenterghem, Y
Citation: Y. Vanrenterghem, Cautious approach to use of non-heart-beating donors, LANCET, 356(9229), 2000, pp. 528-528
Authors:
Vanrenterghem, Y
Lebranchu, Y
Hene, R
Oppenheimer, F
Ekberg, H
Citation: Y. Vanrenterghem et al., Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection, TRANSPLANT, 70(9), 2000, pp. 1352-1359
Authors:
Fritsche, L
Vanrenterghem, Y
Nordal, KP
Grinyo, JM
Moreso, F
Budde, K
Kunz, R
Meyerrose, B
Neumayer, HH
Citation: L. Fritsche et al., Practice variations in the evaluation of adult candidates for cadaveric kidney transplantation - A survey of the European transplant centers, TRANSPLANT, 70(10), 2000, pp. 1492-1497
Authors:
Vanwalleghem, J
Maes, B
Kuypers, D
Messiaen, T
Evenepoel, P
Vanrenterghem, Y
Citation: J. Vanwalleghem et al., Dialysis techniques in the critically-ill patient, ACT CLIN B, 55(5), 2000, pp. 237-243
Authors:
De Meester, JD
Persijn, GG
Smits, JMA
Vanrenterghem, Y
Citation: Jd. De Meester et al., The new Eurotransplant kidney allocation system: a justified balance between equity and utility?, TRANSPLAN I, 12(4), 1999, pp. 299-300
Authors:
Kuypers, D
Vanwalleghem, J
Maes, B
Messiaen, T
Vanrenterghem, Y
Peetermans, WE
Citation: D. Kuypers et al., Cefazolin serum concentrations with fixed intravenous dosing in patients on chronic hemodialysis treatment, NEPH DIAL T, 14(8), 1999, pp. 2050-2051
Authors:
Tsakiris, D
Jones, EHP
Briggs, JD
Elinder, CC
Mehls, O
Mendel, S
Piccoli, G
Rigden, SPA
dos Santos, JP
Simpson, K
Vanrenterghem, Y
Citation: D. Tsakiris et al., Deaths within 90 days from starting renal replacement therapy in the ERA-EDTA Registry between 1990 and 1992, NEPH DIAL T, 14(10), 1999, pp. 2343-2350
Authors:
Elinder, CG
Jones, E
Briggs, JD
Mehls, O
Mendel, S
Piccoli, G
Rigden, SPA
dos Santos, JP
Simpson, K
Tsakiris, D
Vanrenterghem, Y
Citation: Cg. Elinder et al., Improved survival in renal replacement therapy in Europe between 1975 and 1992 - An ERA-EDTA Registry study, NEPH DIAL T, 14(10), 1999, pp. 2351-2356
Authors:
Vanrenterghem, Y
Citation: Y. Vanrenterghem, Strategies to reduce or replace steroid dosing, TRANSPLAN P, 31(8A), 1999, pp. 7S-10S
Authors:
Vanrenterghem, Y
Citation: Y. Vanrenterghem, New horizons in kidney transplantation - March 8-9 1999 Lisbon, Portugal -Introduction, TRANSPLAN P, 31(7A), 1999, pp. 1S-1S
Authors:
Squifflet, JP
Van Hooff, JP
Vanrenterghem, Y
Citation: Jp. Squifflet et al., The Benelux experience with the combination of tacrolimus and mycophenolate mofetil, TRANSPLAN P, 31(7A), 1999, pp. 72S-74S